- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -

FDA Panel Gives Humira the Nod for Colitis

(MedPage Today) — An FDA advisory panel has voted in favor of extending the use of adalimumab (Humira) to ulcerative colitis, which would give patients an additional biologic option for treatment — one they could inject themselves.


Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com